Schizophrenia Clinical Trials

Showing 1-20 of 1,172 trials

A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia

NCT02477020

The purpose of this study is to evaluate the efficacy, safety and tolerability of TAK-063 compared with placebo in treatment of acutely exacerbated schizophrenia.

Schizophrenia

Takeda164 participantsStarted Jul 2015

Springdale, Alaska, United States • Culver City, California, United States • Lemon Grove, California, United States +12 more locations

COMPLETED

Studies of Frontal Lobe Brain Functioning in Schizophrenia

NCT00001258

The purpose of this study is to use brain imaging technology to investigate the role of the frontal lobe of the brain in the thinking of individuals with schizophrenia and other neuropsychiatric disorders and healthy volunteers. Participants in this study will undergo a positron emission tomography (PET) scan of the brain while performing neuropsychological tests. Some of the tests involve cognitive operations that depend upon the frontal cortex. Interactions between frontal lobe activation, cognitive behavior, and neuropharmacology will be assessed by measuring regional cerebral blood flow (rCBF) during treatment with drugs that may affect frontal lobe physiology.

Healthy SubjectsSchizophreniaParkinson Disease

National Institute of Mental Health (NIMH)1,039 participantsStarted Nov 1993

Bethesda, Maryland, United States

COMPLETED

Genetic Study of Schizophrenia

NCT00001486

This large ongoing study at NIMH investigates the neurobiology of schizophrenia by identifying susceptibility genes, evaluating their impact on brain function to better understand how to treat and prevent this illness....

Schizoaffective DisorderSchizophrenia

National Institute of Mental Health (NIMH)4,914 participantsStarted Jul 1995

Bethesda, Maryland, United States

A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia

Studies of Frontal Lobe Brain Functioning in Schizophrenia

Genetic Study of Schizophrenia

Related Searches

Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.

A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

THE EFFECTS OF AN ONLINE FAMILY PSYCHOEDUCATION PROGRAM ON EXPRESSED EMOTION OF FAMILY MEMBERS AND MEDICATION ADHERENCE OF PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine

Synbiotic Compound to Reduce Symptoms of Schizophrenia

Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component

Theta-burst rTMS in Schizophrenia to Ameliorate Negative and Cognitive Symptoms

Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia

Peer-led Psycho-education for Schizophrenia

Arts-based Social Prescribing for Mental Health

ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention

Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients

TIS for Improving Cognitive Impairment Associated With Schizophrenia

Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study